Corcept Therapeutics Incorporated
CORT
$115.70
$1.721.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 235.35% | -230.77% | 23.49% | -44.04% | 71.07% |
| Total Depreciation and Amortization | 44.31% | 24.07% | 1.05% | 1.71% | 1.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 247.26% | 102.47% | -85.50% | 58,567.92% | -100.82% |
| Change in Net Operating Assets | -891.41% | -42.36% | 174.34% | -61.66% | 138.52% |
| Cash from Operations | 299.99% | -143.62% | -29.43% | 22.99% | 828.66% |
| Capital Expenditure | -1,157.71% | -302.00% | -- | 100.00% | 45.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -663.23% | 140.22% | -180.53% | -79.13% | 2,388.36% |
| Cash from Investing | -743.81% | 138.35% | -180.87% | -79.12% | 2,311.51% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 44.46% | 22.53% | 26.62% | -66.40% | 262.08% |
| Repurchase of Common Stock | -98.87% | 84.23% | 27.81% | 56.16% | -166.87% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -368.03% | 102.43% | 32.74% | 54.91% | -158.61% |
| Foreign Exchange rate Adjustments | 112.89% | -796.88% | 90.00% | -122.28% | 301.12% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 119.57% | -153.22% | -120.73% | 73.24% | 134.15% |